165 related articles for article (PubMed ID: 31345390)
1. Establishment of syngeneic murine model for oral cancer therapy.
Chen YF; Chang KW; Yang IT; Tu HF; Lin SC
Oral Oncol; 2019 Aug; 95():194-201. PubMed ID: 31345390
[TBL] [Abstract][Full Text] [Related]
2. Establishing of mouse oral carcinoma cell lines derived from transgenic mice and their use as syngeneic tumorigenesis models.
Chen YF; Liu CJ; Lin LH; Chou CH; Yeh LY; Lin SC; Chang KW
BMC Cancer; 2019 Mar; 19(1):281. PubMed ID: 30922255
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-211 Enhances the Oncogenicity of Carcinogen-Induced Oral Carcinoma by Repressing TCF12 and Increasing Antioxidant Activity.
Chen YF; Yang CC; Kao SY; Liu CJ; Lin SC; Chang KW
Cancer Res; 2016 Aug; 76(16):4872-86. PubMed ID: 27221705
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor.
Lin SC; Kao SY; Chang JC; Liu YC; Yu EH; Tseng SH; Liu CJ; Chang KW
Oncotarget; 2016 Sep; 7(38):61355-61365. PubMed ID: 27542258
[TBL] [Abstract][Full Text] [Related]
5. Impact of combination immunochemotherapies on progression of 4NQO-induced murine oral squamous cell carcinoma.
Ludwig S; Hong CS; Razzo BM; Fabian KPL; Chelvanambi M; Lang S; Storkus WJ; Whiteside TL
Cancer Immunol Immunother; 2019 Jul; 68(7):1133-1141. PubMed ID: 31139925
[TBL] [Abstract][Full Text] [Related]
6.
García-Carracedo D; Cai Y; Qiu W; Saeki K; Friedman RA; Lee A; Li Y; Goldberg EM; Stratikopoulos EE; Parsons R; Lu C; Efstratiadis A; Philipone EM; Yoon AJ; Su GH
Mol Cancer Res; 2020 Jun; 18(6):822-834. PubMed ID: 32152233
[TBL] [Abstract][Full Text] [Related]
7. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of microRNA-17 enhances cisplatin-induced apoptosis of human tongue squamous carcinoma cell.
Sun Y; Nie W; Qiu B; Guo X; Zhang J; Wei J
J Bioenerg Biomembr; 2021 Apr; 53(2):169-176. PubMed ID: 33462751
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a
Chang KW; Lin CE; Tu HF; Chung HY; Chen YF; Lin SC
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302499
[TBL] [Abstract][Full Text] [Related]
10. Beta-adrenergic blocker inhibits oral carcinogenesis and reduces tumor invasion.
Cecilio HP; Valente VB; Pereira KM; Kayahara GM; Furuse C; Biasoli ÉR; Miyahara GI; Oliveira SHP; Bernabé DG
Cancer Chemother Pharmacol; 2020 Nov; 86(5):681-686. PubMed ID: 32980903
[TBL] [Abstract][Full Text] [Related]
11. Isolation of differentiated squamous and undifferentiated spindle carcinoma cell lines with differing metastatic potential from a 4-nitroquinoline N-Oxide-induced tongue carcinoma in a F344 rat.
Takeuchi S; Nakanishi H; Yoshida K; Yamamoto S; Tonoki H; Tsukamoto T; Fukushima S; Moriuchi T; Kurita K; Tatematsu M
Jpn J Cancer Res; 2000 Dec; 91(12):1211-21. PubMed ID: 11123419
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines.
Yu ZW; Zhong LP; Ji T; Zhang P; Chen WT; Zhang CP
Oral Oncol; 2010 Apr; 46(4):317-22. PubMed ID: 20219416
[TBL] [Abstract][Full Text] [Related]
13. MiR-155 Inhibitor-Laden Exosomes Reverse Resistance to Cisplatin in a 3D Tumor Spheroid and Xenograft Model of Oral Cancer.
Sayyed AA; Gondaliya P; Mali M; Pawar A; Bhat P; Khairnar A; Arya N; Kalia K
Mol Pharm; 2021 Aug; 18(8):3010-3025. PubMed ID: 34176265
[TBL] [Abstract][Full Text] [Related]
14. Impact of Tenascin-C on Radiotherapy in a Novel Syngeneic Oral Squamous Cell Carcinoma Model With Spontaneous Dissemination to the Lymph Nodes.
Spenlé C; Loustau T; Burckel H; Riegel G; Abou Faycal C; Li C; Yilmaz A; Petti L; Steinbach F; Ahowesso C; Jost C; Paul N; Carapito R; Noël G; Anjuère F; Salomé N; Orend G
Front Immunol; 2021; 12():636108. PubMed ID: 34290694
[TBL] [Abstract][Full Text] [Related]
15. Activation of the
Lin SC; Wu HL; Yeh LY; Yang CC; Kao SY; Chang KW
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322437
[TBL] [Abstract][Full Text] [Related]
16. K14-EGFP-miR-31 transgenic mice have high susceptibility to chemical-induced squamous cell tumorigenesis that is associating with Ku80 repression.
Tseng SH; Yang CC; Yu EH; Chang C; Lee YS; Liu CJ; Chang KW; Lin SC
Int J Cancer; 2015 Mar; 136(6):1263-75. PubMed ID: 25082302
[TBL] [Abstract][Full Text] [Related]
17. Fat mass and obesity-associated protein regulates tumorigenesis of arecoline-promoted human oral carcinoma.
Li X; Xie X; Gu Y; Zhang J; Song J; Cheng X; Gao Y; Ai Y
Cancer Med; 2021 Sep; 10(18):6402-6415. PubMed ID: 34378866
[TBL] [Abstract][Full Text] [Related]
18. Bcl-xL expression and regulation in the progression, recurrence, and cisplatin resistance of oral cancer.
Alam M; Mishra R
Life Sci; 2021 Sep; 280():119705. PubMed ID: 34111459
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancer.
Fournel L; Wu Z; Stadler N; Damotte D; Lococo F; Boulle G; Ségal-Bendirdjian E; Bobbio A; Icard P; Trédaniel J; Alifano M; Forgez P
Cancer Lett; 2019 Nov; 464():5-14. PubMed ID: 31404614
[TBL] [Abstract][Full Text] [Related]
20. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
Wang X; Li H; Shi J
Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
